A health-tracking system you can swallow  Novartis plans to seek
regulatory approval for a pill for transplant patients that
carries a microchip activated by stomach acid and can track
health data.   The silicon and metal sensor sends data via a
faint radio signal to a patch on the patient's skin. Proteus
Biomedical   "We hope within the next 18 months to have
something that we will be able to submit to the regulators,"
global head of development Trevor Mundel told the Reuters Health
Summit in New York this week. "The regulators all like the
concept and have been very encouraging. But...they want to
understand how we are going to solve the data privacy issues."
The silicon and metal sensor, which sends data via a faint radio
signal to a patch on a patient's skin that then transmits the
information wirelessly to a designated smartphone, e-mail
account, etc., is first being studied in a drug for transplant
patients that helps avoid organ rejection.  Since the drug
itself is already approved and established, No